| (Values in U.S. Thousands) | Jun, 2015 | Jun, 2014 | Jun, 2013 | Jun, 2012 | Jun, 2011 |
| Sales | 12,990 | 8,550 | 12,020 | 3,410 | 6,650 |
| Sales Growth | +51.93% | -28.87% | +252.49% | -48.72% | +91.64% |
| Net Income | -21,540 | -21,010 | -27,350 | -14,640 | -15,550 |
| Net Income Growth | -2.52% | +23.18% | -86.82% | +5.85% | -0.19% |
Implant Sciences Cp (IMSC)
0.1250 +0.0121 (+10.72%) 10/11/16 [OTC US]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Tue, Oct 11th, 2016
Implant Sciences Corporation a developer and manufacturer of products for the national security, semiconductor and medical industries, uses its patented ion beam technology to develop, manufacture and sell products through its primary business units: (i) trace explosives detection systems for homeland security, defense, and other security related applications and (ii) state of the art services for the medical and semiconductor industries. The Company has developed and begun shipments of handheld, portable trace explosive detection systems to a growing number of locations around the world and domestically. Building on several core technological capabilities, the Company is working on the development of several next generation trace explosives detection systems. The Company believes its strong background in ion beam technology addresses many important security needs in aviation, cargo, transportation, and other related elements of the government and commercial infrastructure.